Information  X 
Enter a valid email address

Antisoma plc (SRC)

  Print      Mail a friend       Annual reports

Monday 25 June, 2007

Antisoma plc

Antisoma to present at Jeffries Healthcare Conf...

25 June 2007, London, UK - Antisoma plc (LSE: ASM; USOTC: ATSMY)
announces that its Director of Communications, Dr Daniel Elger, will
be presenting at the Jeffries Healthcare Conference in New York, USA,
on Wednesday June 27th.

Dr Elger's presentation is scheduled for 16:10 EDT (21:10 BST). A
webcast of the presentation will be available to all on Antisoma's
website at

It is recommended that viewers log on 15 minutes early in order to
register and download any necessary software.


Chris Elston                                                      +44
(0)20 8799 8200
Communications Manager
Antisoma plc

Background on Antisoma
Based in London, UK, Antisoma is a biopharmaceutical company that
develops novel products for the treatment of cancer. Antisoma fills
its development pipeline by acquiring promising new product
candidates from internationally recognised academic or cancer
research institutions. Its core activity is the preclinical and
clinical development of these drug candidates. Please visit for further information.